These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28639453)

  • 1. Atypical Primary Cutaneous Rosai Dorfman Disease: A Case Report.
    Kinio AE; Sawchuk MA; Pratt M
    J Cutan Med Surg; 2017; 21(5):460-463. PubMed ID: 28639453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple nodules and plaques on the face and trunk. Cutaneous Rosai-Dorfman disease (RDD).
    Wartman DG; Perry A; Werchniak AE
    Arch Dermatol; 2006 Nov; 142(11):1501-6. PubMed ID: 17116845
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous Rosai-Dorfman disease.
    Gaul M; Chang T
    Cutis; 2019 Mar; 103(3):171-173. PubMed ID: 31039225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
    Frater JL; Maddox JS; Obadiah JM; Hurley MY
    J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosai-Dorfman disease successfully treated with thalidomide: A case report.
    Shahidi-Dadras M; Hamedani B; Niknezhad N; Ghilizadeh N
    Dermatol Ther; 2019 Sep; 32(5):e13005. PubMed ID: 31228316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of large cutaneous facial Rosai-Dorfman disease using combination of subtotal resection and ALA-PDT: A case report.
    Wan M; Ding A; Liu H; Ou J; Zhang J
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101879. PubMed ID: 32562733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive purely cutaneous Rosai-Dorfman disease responsive to acitretin.
    Mebazaa A; Trabelsi S; Denguezli M; Sriha B; Belajouza C; Nouira R
    Int J Dermatol; 2007 Nov; 46(11):1208-10. PubMed ID: 17988346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indolent firm reddish papules. Cutaneous Rosai-Dorfman disease].
    Bens G; Kerdraon R; De Kyvon JJ; Estève E
    Hautarzt; 2011 May; 62(5):384-7. PubMed ID: 21431448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Purely cutaneous Rosai-Dorfman disease].
    Plettenberg H; Artik S; Kuhn A; Megahed M; Ruzicka T; Kruse R
    Hautarzt; 2004 Oct; 55(10):969-71. PubMed ID: 15351867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review.
    Mosheimer BA; Oppl B; Zandieh S; Fillitz M; Keil F; Klaushofer K; Weiss G; Zwerina J
    Curr Rheumatol Rep; 2017 May; 19(5):29. PubMed ID: 28401384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Healing Extranodal Cutaneous Rosai-Dorfman in a Child.
    Toledo del Castillo B; Mata-Fernández C; Rodríguez Soria VJ; Parra Blanco V; Loughlin G; Campos-Domínguez M
    Pediatr Dermatol; 2015; 32(6):e249-50. PubMed ID: 26391332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
    Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
    Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional laser combined with 5-Aminolevulinic acid photodynamic therapy for the treatment of Cutaneous Rosai-Dorfman Disease: A case report.
    Wang H; Wang C; Wang X; Zhang L; Zhang M; Ge L; You Y
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103852. PubMed ID: 37858909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroid responsive cutaneous Rosai-Dorfman disease associated with uveitis and hypothyroidism.
    Salim A; Williamson M; Barker F; Hughes J
    Clin Exp Dermatol; 2002 Jun; 27(4):277-9. PubMed ID: 12139669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease.
    Hoyo-Muñoz A; Collado-Borrell R; Escudero-Vilaplana V; Bastos-Oreiro M; Herranz-Alonso A; Sanjurjo-Sáez M
    J Clin Pharm Ther; 2022 Apr; 47(4):548-551. PubMed ID: 34514634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of intracranial Rosai-Dorfman disease.
    Wahba M
    Hosp Pract (1995); 2013; 41(4):83-6. PubMed ID: 24145594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system.
    Le Guenno G; Galicier L; Uro-Coste E; Petitcolin V; Rieu V; Ruivard M
    J Neurosurg; 2012 Sep; 117(3):486-9. PubMed ID: 22725985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial cutaneous Rosai-Dorfman disease: a case report.
    Wongrat T; Sangmala S
    J Med Case Rep; 2024 Mar; 18(1):182. PubMed ID: 38532442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.